TNFRSF1A (TNF receptor superfamily member 1A)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
7132 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
TNF receptor superfamily member 1A |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
TNFRSF1A |
SynonymsGene synonyms aliases
|
CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR55, TNFR60, p55, p55-R, p60 |
ChromosomeChromosome number
|
12 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
12p13.31 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a member of the TNF receptor superfamily of proteins. The encoded receptor is found in membrane-bound and soluble forms that interact with membrane-bound and soluble forms, respectively, of its ligand, tumor necrosis factor alpha. Binding of membrane-bound tumor necrosis factor alpha to the membrane-bound receptor induces receptor trimerization and activation, which plays a role in cell survival, apoptosis, and inflammation. Proteolytic processing of the encoded receptor results in release of the soluble form of the receptor, which can interact with free tumor necrosis factor alpha to inhibit inflammation. Mutations in this gene underlie tumor necrosis factor receptor-associated periodic syndrome (TRAPS), characterized by fever, abdominal pain and other features. Mutations in this gene may also be associated with multiple sclerosis in human patients. [provided by RefSeq, Sep 2016] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs1800693 |
T>C |
Benign, risk-factor, likely-benign |
Intron variant |
rs4149584 |
C>G,T |
Conflicting-interpretations-of-pathogenicity, pathogenic |
Coding sequence variant, 5 prime UTR variant, missense variant, non coding transcript variant |
rs34751757 |
G>A,T |
Not-provided, conflicting-interpretations-of-pathogenicity |
Non coding transcript variant, 5 prime UTR variant, coding sequence variant, missense variant |
rs104895217 |
A>G |
Pathogenic |
Non coding transcript variant, 5 prime UTR variant, intron variant, coding sequence variant, missense variant |
rs104895218 |
C>T |
Pathogenic |
Non coding transcript variant, 5 prime UTR variant, intron variant, coding sequence variant, missense variant |
rs104895219 |
G>A,T |
Pathogenic, not-provided |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895220 |
C>A,T |
Pathogenic, not-provided |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895221 |
A>G |
Pathogenic |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895222 |
C>T |
Pathogenic |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895223 |
C>A,G,T |
Pathogenic, not-provided, uncertain-significance |
Non coding transcript variant, 5 prime UTR variant, intron variant, coding sequence variant, missense variant |
rs104895224 |
C>G,T |
Pathogenic, not-provided |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895225 |
A>C |
Pathogenic, likely-pathogenic |
Non coding transcript variant, 5 prime UTR variant, intron variant, coding sequence variant, missense variant |
rs104895228 |
A>C,G,T |
Pathogenic, not-provided |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895232 |
A>G |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895245 |
A>C,G |
Likely-pathogenic, not-provided, uncertain-significance |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895247 |
A>G,T |
Pathogenic, not-provided, uncertain-significance |
Coding sequence variant, intron variant, missense variant |
rs104895253 |
A>G |
Likely-pathogenic, not-provided |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs104895271 |
A>C,G |
Likely-benign, pathogenic, likely-pathogenic |
Synonymous variant, non coding transcript variant, 5 prime UTR variant, intron variant, coding sequence variant, missense variant |
rs104895276 |
G>A,C |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, 5 prime UTR variant, missense variant |
rs200900510 |
C>T |
Benign, pathogenic, conflicting-interpretations-of-pathogenicity |
Missense variant, non coding transcript variant, coding sequence variant |
rs756455040 |
G>T |
Conflicting-interpretations-of-pathogenicity |
Non coding transcript variant, synonymous variant, coding sequence variant |
rs876661014 |
G>C |
Uncertain-significance, likely-pathogenic |
5 prime UTR variant, coding sequence variant, non coding transcript variant, missense variant |
rs876661031 |
C>T |
Likely-pathogenic |
5 prime UTR variant, coding sequence variant, non coding transcript variant, missense variant |
rs886039866 |
G>A |
Pathogenic |
5 prime UTR variant, coding sequence variant, non coding transcript variant, missense variant |
rs1555108112 |
C>G,T |
Likely-pathogenic |
Missense variant, non coding transcript variant, 5 prime UTR variant, coding sequence variant |
rs1592047560 |
->TGTGTCTTGCAC |
Pathogenic |
5 prime UTR variant, coding sequence variant, non coding transcript variant, inframe insertion |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000139 |
Component |
Golgi membrane |
IDA |
22801493 |
GO:0002947 |
Component |
Tumor necrosis factor receptor superfamily complex |
TAS |
24966471 |
GO:0003176 |
Process |
Aortic valve development |
ISS |
|
GO:0003177 |
Process |
Pulmonary valve development |
ISS |
|
GO:0003332 |
Process |
Negative regulation of extracellular matrix constituent secretion |
ISS |
|
GO:0005031 |
Function |
Tumor necrosis factor-activated receptor activity |
IBA |
21873635 |
GO:0005031 |
Function |
Tumor necrosis factor-activated receptor activity |
TAS |
2158863 |
GO:0005515 |
Function |
Protein binding |
IPI |
1087798, 2848815, 7758105, 8565075, 8943045, 8985253, 9115275, 10848577, 11684708, 12887920, 14743216, 15465831, 16611992, 18022363, 19524513, 19641494, 19781631, 20080539, 20103630, 22028622, 22817896, 23955153, 24070898, 24130170, 24440909, 25241761, 25911380, 30561431 |
GO:0005576 |
Component |
Extracellular region |
NAS |
12189246 |
GO:0005576 |
Component |
Extracellular region |
TAS |
|
GO:0005615 |
Component |
Extracellular space |
IDA |
13130484 |
GO:0005739 |
Component |
Mitochondrion |
IBA |
21873635 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005887 |
Component |
Integral component of plasma membrane |
TAS |
1698610 |
GO:0006693 |
Process |
Prostaglandin metabolic process |
IEA |
|
GO:0006954 |
Process |
Inflammatory response |
IBA |
21873635 |
GO:0006954 |
Process |
Inflammatory response |
ISS |
|
GO:0007249 |
Process |
I-kappaB kinase/NF-kappaB signaling |
TAS |
|
GO:0008625 |
Process |
Extrinsic apoptotic signaling pathway via death domain receptors |
TAS |
8612133 |
GO:0008630 |
Process |
Intrinsic apoptotic signaling pathway in response to DNA damage |
IEA |
|
GO:0009986 |
Component |
Cell surface |
IEA |
|
GO:0010614 |
Process |
Negative regulation of cardiac muscle hypertrophy |
IEA |
|
GO:0010803 |
Process |
Regulation of tumor necrosis factor-mediated signaling pathway |
TAS |
|
GO:0016020 |
Component |
Membrane |
TAS |
24966471 |
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
ISS |
|
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
TAS |
|
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
IMP |
25816133 |
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
TAS |
24966471 |
GO:0042531 |
Process |
Positive regulation of tyrosine phosphorylation of STAT protein |
IMP |
21410936 |
GO:0042742 |
Process |
Defense response to bacterium |
IEA |
|
GO:0043120 |
Function |
Tumor necrosis factor binding |
IBA |
21873635 |
GO:0043120 |
Function |
Tumor necrosis factor binding |
IPI |
9435233 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IEP |
12761501 |
GO:0043235 |
Component |
Receptor complex |
IBA |
21873635 |
GO:0043235 |
Component |
Receptor complex |
IDA |
23382219 |
GO:0045121 |
Component |
Membrane raft |
IBA |
21873635 |
GO:0045121 |
Component |
Membrane raft |
IDA |
17010968 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
21410936 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
ISS |
|
GO:0050728 |
Process |
Negative regulation of inflammatory response |
IMP |
13130484 |
GO:0050729 |
Process |
Positive regulation of inflammatory response |
ISS |
|
GO:0071260 |
Process |
Cellular response to mechanical stimulus |
IEP |
19593445 |
GO:0071550 |
Process |
Death-inducing signaling complex assembly |
TAS |
|
GO:0072659 |
Process |
Protein localization to plasma membrane |
IMP |
25816133 |
GO:1902339 |
Process |
Positive regulation of apoptotic process involved in morphogenesis |
ISS |
|
GO:1903140 |
Process |
Regulation of establishment of endothelial barrier |
IMP |
25816133 |
GO:2000304 |
Process |
Positive regulation of ceramide biosynthetic process |
TAS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P19438 |
Protein name |
Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)] |
Protein function |
Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase. |
PDB |
1EXT
,
1FT4
,
1ICH
,
1NCF
,
1TNR
,
7K7A
,
7KP7
,
7KP8
,
7KPB
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00020 |
TNFR_c6 |
44 → 81 |
TNFR/NGFR cysteine-rich region |
Domain |
PF00020 |
TNFR_c6 |
84 → 125 |
TNFR/NGFR cysteine-rich region |
Domain |
PF00020 |
TNFR_c6 |
127 → 166 |
TNFR/NGFR cysteine-rich region |
Domain |
PF00531 |
Death |
356 → 441 |
Death domain |
Domain |
|
Sequence |
|
Sequence length |
455 |
Interactions |
View interactions |
|
|